A028300 Stock Overview
Manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
HLB Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩73,600.00 |
52 Week High | ₩129,000.00 |
52 Week Low | ₩31,650.00 |
Beta | 0.27 |
11 Month Change | 15.36% |
3 Month Change | -15.21% |
1 Year Change | 123.71% |
33 Year Change | 120.83% |
5 Year Change | 74.19% |
Change since IPO | 3,656.84% |
Recent News & Updates
Recent updates
Does HLB (KOSDAQ:028300) Have A Healthy Balance Sheet?
Aug 25Does HLB (KOSDAQ:028300) Have A Healthy Balance Sheet?
Feb 26Is HLB (KOSDAQ:028300) A Risky Investment?
May 08What Kind Of Investors Own Most Of HLB Co., Ltd. (KOSDAQ:028300)?
Mar 16Can You Imagine How Elated HLB's (KOSDAQ:028300) Shareholders Feel About Its 486% Share Price Gain?
Dec 09Shareholder Returns
A028300 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -2.5% | -2.7% | -3.3% |
1Y | 123.7% | 9.6% | -5.4% |
Return vs Industry: A028300 exceeded the KR Medical Equipment industry which returned 9.6% over the past year.
Return vs Market: A028300 exceeded the KR Market which returned -5.4% over the past year.
Price Volatility
A028300 volatility | |
---|---|
A028300 Average Weekly Movement | 10.4% |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 5.7% |
10% most volatile stocks in KR Market | 11.7% |
10% least volatile stocks in KR Market | 2.8% |
Stable Share Price: A028300's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A028300's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1975 | 160 | Jung-Min Park | hlbbio.co.kr |
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. HLB Co., Ltd.
HLB Co., Ltd. Fundamentals Summary
A028300 fundamental statistics | |
---|---|
Market cap | ₩9.36t |
Earnings (TTM) | -₩185.77b |
Revenue (TTM) | ₩51.92b |
185.9x
P/S Ratio-52.0x
P/E RatioIs A028300 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A028300 income statement (TTM) | |
---|---|
Revenue | ₩51.92b |
Cost of Revenue | ₩44.40b |
Gross Profit | ₩7.53b |
Other Expenses | ₩193.30b |
Earnings | -₩185.77b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.42k |
Gross Margin | 14.49% |
Net Profit Margin | -357.79% |
Debt/Equity Ratio | 23.6% |
How did A028300 perform over the long term?
See historical performance and comparison